Other grades of this product :
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Basic information |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: soluble10mg/mL | | form | powder | | color | white to beige |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Usage And Synthesis |
| Biochem/physiol Actions | DDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin. |
| 3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Preparation Products And Raw materials |
|